Intra-Cellular Therapies (ITCI):
The Institutional ownership of the firm is 81.00% while Insiders ownership is 1.50%. Company has kept return on investment (ROI) at -22.60% over the previous 12 months and has been able to maintain return on asset (ROA) at -30.30% for the last twelve months. Return on equity (ROE) recorded at -31.70%.
Intra-Cellular Therapies (ITCI) revealed a move of -1.27% placing the stock price at $18.6 per share in recent trading session ended on Wednesday. The latest trading activity showed that the stock price is 33.52% off from its 52-week low and traded with move of -27.96% from high printed in the last 52-week period. The Company kept 48M Floating Shares and holds 56.68M shares outstanding.
The company’s earnings per share shows growth of 20.50% for the current year and expected to arrive earnings growth for the next year at -9.50% . The company’s EPS growth rate for past five years was 6.30%. The earnings growth rate for the next years is an important measure for investors planning to hold onto a stock for several years. The company’s earnings will usually have a direct relationship to the price of the company’s stock. The stock observed Sales growth of -39.80% during past 5 years. EPS growth quarter over quarter stands at -67.10%.
Shares price moved with -21.25% from its 50 Day high and distanced at 4.85% from 50 Day low. Analyses consensus rating score stands at 1.6. For the next one year period, the average of individual price target estimates referred by covering sell-side analysts is $30.4.
Intra-Cellular Therapies (ITCI) stock recent traded volume stands with 441391 shares as compared with its average volume of 294.4K shares. The relative volume observed at 1.5.
Trading volume, or volume, is the number of shares or contracts that indicates the overall activity of a security or market for a given period. Trading volume is an important technical indicator an investor uses to confirm a trend or trend reversal. Volume gives an investor an idea of the price action of a security and whether he should buy or sell the security.
Volume analysis is used by technical analysts to determine the strength of price movement, as some believe price follows volume. For example, if the price of a stock is going up, but volume is declining, it can be a bearish signal. On the hand, if price is declining and volume is rising, it is definitely a bearish sign.
The current ratio of 21.6 is mainly used to give an idea of a company’s ability to pay back its liabilities (debt and accounts payable) with its assets (cash, marketable securities, inventory, accounts receivable). As such, current ratio can be used to make a rough estimate of a company’s financial health. The quick ratio of 21.6 is a measure of how well a company can meet its short-term financial liabilities with quick assets (cash and cash equivalents, short-term marketable securities, and accounts receivable). The higher the ratio, the more financially secure a company is in the short term. A common rule of thumb is that companies with a quick ratio of greater than 1.0 are sufficiently able to meet their short-term liabilities.
The long term debt/equity shows a value of 0 with a total debt/equity of 0. It gives the investors the idea on the company’s financial leverage, measured by apportioning total liabilities by its stockholders equity. It also illustrates how much debt the corporation is using to finance its assets in relation to the value represented in shareholders’ equity.
SMA and Trends:
Moving averages are valuable, as they smooth daily fluctuations, allowing the technical analyst to see the underlying trend without being distracted by the small (daily) movements. A rising moving average usually signals an uptrend, while a falling moving average indicates a downtrend.
Some analysts have adopted the following approach, when it comes to relating the SMA with a particular trend: If the close price of a tradable instrument is above some simple moving average, then the trend must be bullish. If the close price is below some simple moving average, then the trend must be bearish. However, choosing a period for trend estimation is a matter of personal preferences. The period of the SMA will depend on one’s trading style and time frame for trading. Thus, choosing the appropriate period comes with experimentation and, of course, experience. Despite that simple moving averages provide help when identifying a trend, they do so after the trend has begun. Therefore, moving averages are lagging indicators, as they are based on past prices.
Intra-Cellular Therapies (ITCI) stock moved down -11.63% in contrast to its 20 day moving average displaying short-term a downside movement of stock. It shifted -11.39% down its 50-day simple moving average. This is showing medium-term pessimistic trend based on SMA 50. The stock price went below -7.46% from its 200-day simple moving average identifying long-term declining trend.
Larry Spivey – Category – Business
Larry Spivey also covers the business news across all market sectors. He also has an enormous knowledge of stock market. He holds an MBA degree from University of Florida. He has more than 10 years of experience in writing financial and market news. Larry previously worked at a number of companies in different role including web developer, software engineer and product manager. He currently covers Business news section.